넙치, Paralichthys olivaceus에 nalidixic acid, piromidic acid, oxolinic acid의 경구투여 약물동태에 미치는 수온의 영향

Effect of temperature on pharmacokinetics of nalidixic acid, piromidic acid and oxolinic acid in olive flounder Paralichthys olivaceus following oral administration

  • 정승희 (국립수산과학원 전략양식연구소 병리연구과) ;
  • 김진우 (국립수산과학원 수산생물방역과) ;
  • 서정수 (국립수산과학원 수산생물방역과) ;
  • 최동림 (국립수산과학원 전략양식연구소 병리연구과) ;
  • 지보영 (국립수산과학원 수산생물방역과) ;
  • 박명애 (국립수산과학원 전략양식연구소 병리연구과)
  • Jung, Sung-Hee (Pathology Division, Aquaculture Research Institute, National Fisheries Research & Development Institute) ;
  • Kim, Jin-Woo (Aquatic Life Disease Control Division, NFRDI) ;
  • Seo, Jung-Soo (Aquatic Life Disease Control Division, NFRDI) ;
  • Choi, Dong-Lim (Pathology Division, Aquaculture Research Institute, National Fisheries Research & Development Institute) ;
  • Jee, Bo-Young (Aquatic Life Disease Control Division, NFRDI) ;
  • Park, Myoung-Ae (Pathology Division, Aquaculture Research Institute, National Fisheries Research & Development Institute)
  • 투고 : 2010.02.22
  • 심사 : 2010.04.23
  • 발행 : 2010.04.30

초록

퀴놀론계 항균제인 nalidixic acid(OA), piromidic acid(PA), oxolinic acid(OA)를 사육수온($13{\pm}1.5^{\circ}C$, $23{\pm}1.5^{\circ}C$)에 따라서 넙치(평균체중 700 g)에 60 mg/kg의 농도로 1회 경구 투여한 다음, 경시적인 혈청내 잔류농도를 분석하였다. 수온이 $23{\pm}1.5^{\circ}C$의 경우, 투여 후 NA는 10시간째 ($11.55{\mu}g/m\ell$), PA는 24시간째($3.79{\mu}g/m\ell$), OA는 30시간째($1.12{\mu}g/m\ell$)에 각각 최대혈중농도에 도달하였다. 수온이 $13{\pm}1.5^{\circ}C$의 경우, 투여 후 NA는 10시간째($6.36{\mu}g/m\ell$), PA는 15시간째($1.4{\mu}g/m\ell$), OA는 30시간째($1.01{\mu}g/m\ell$)에 각각 최대혈중농도에 도달하였다. NA와 PA의 넙치 혈중내 흡수정도는 수온 $13{\pm}1.5^{\circ}C$보다 수온 $23{\pm}1.5^{\circ}C$에서 매우 높게 나타났으며, NA의 넙치 혈중내 소실정도는 수온 $13{\pm}1.5^{\circ}C$보다 수온 $23{\pm}1.5^{\circ}C$에서 두드러지게 빨랐다. 한편 OA의 넙치 혈중내 흡수 및 소실정도는 사육수온에 크게 영향을 받지 않는 것으로 나타났다. NA 및 PA는 one-compartment model, OA는 two-compartment model로 해석하여 WinNonlin program을 이용, 약물동태학적 매개변수(parameter)를 조사하였다. 수온이 $23{\pm}1.5^{\circ}C$의 경우, 혈장농도-시간곡선하 면적(AUC)은 NA, PA, OA가 각각 258.26, 248.12 및 $138.20{\mu}g{\cdot}h/m\ell$, 혈중최고농도의 도달시간($T_{max}$)은 10.67, 21.15 및 23.95 h, 혈중최고농도($C_{max}$)는 8.91, 3.09 및 $1.06{\mu}g/m\ell$로 계산되었다. 수온이 $13{\pm}1.5^{\circ}C$의 경우, AUC는 NA, PA, OA가 각각 341.45, 103.89 및 $159.10{\mu}g{\cdot}h/m\ell$, 혈중최고농도의 도달시간은 7.72, 12.89 및 28.03 h, 혈중최고농도는 6.23, 1.22 및 $1.02{\mu}g/m\ell$로 계산되었다.

Effects of temperature ($13{\pm}1.5^{\circ}C$, $23{\pm}1.5^{\circ}C$) on the pharmacokinetic properties of nalidixic acid (NA), piromidic acid (PA) and oxolinic acid (OA) were studied after oral administration to cultured olive flounder, Paralichthys olivaceus. Serum concentrations of these antimicrobials were determined after oral administration of a single dosage of 60 mg/kg body weight (average 700 g). At $23{\pm}1.5^{\circ}C$, the peak serum concentrations of NA, PA and OA, which attained at 10 h, 24 h and 30 h post-dose, were 11.55, 3.79 and $1.12{\mu}g/m\ell$, respectively. At $13{\pm}1.5^{\circ}C$, the peak serum concentrations of NA, PA and OA, which attained at 10 h, 15 h and 30 h post-dose, were 6.36, 1.4 and $1.01{\mu}g/m\ell$, respectively. Better absorption of NA and PA was noted at $23{\pm}1.5^{\circ}C$ compared to $23{\pm}13^{\circ}C$. The elimination of NA from serum of olive flounder was considerably faster at $23{\pm}1.5^{\circ}C$ than at $13{\pm}1.5^{\circ}C$. However, both absorption and elimination of OA were not affected significantly by temperature. The kinetic profile of absorption, distribution and elimination of these antimicrobials in serum were analyzed by fitting to a one- and two compartment model, with WinNonlin program. In the one compartment model for NA, AUC, Tmax and Cmax at $23{\pm}1.5^{\circ}C$ were $258.26{\mu}g{\cdot}h/m\ell$, 10.67 h and $8.91{\mu}g/m\ell$, respectively. The AUC, $T_{max}$ and $C_{max}$ at $13{\pm}1.5^{\circ}C$ were $341.45 {\mu}g{\cdot}h/m\ell$, 7.72 h and $6.23{\mu}g/m\ell$, respectively. In the one compartment model for PA, AUC, $T_{max}$ and $C_{max}$ at $23{\pm}1.5^{\circ}C$ were $248.12{\mu}g{\cdot}h/m\ell$, 21.15 h and $3.09{\mu}g/m\ell$, respectively. The AUC, $T_{max}$ and $C_{max}$ at $13{\pm}1.5^{\circ}C$ were $103.89{\mu}g{\cdot}h/m\ell$, 12.89 h and $1.22{\mu}g/m\ell$, respectively. In the two compartment model for OA, AUC, $T_{max}$ and $C_{max}$ at $23{\pm}1.5^{\circ}C$ were $138.20{\mu}g{\cdot}h/m\ell$, 23.95 h and $1.06{\mu}g/m\ell$, respectively. The AUC, $T_{max}$ and $T_{max}$ at $13{\pm}1.5^{\circ}C$ were $159.10{\mu}g{\cdot}h/m\ell$, 28.03 h and $1.02{\mu}g/m\ell$, respectively.

키워드

참고문헌

  1. Barron, M.G., Stehly, G.R. and Hayton, W.L.: Pharmacokinetic modeling in aquatic animals. I. Models and concepts. Aquatic Toxicology, 18:61-86, 1990. https://doi.org/10.1016/0166-445X(90)90019-L
  2. Björklund, H. and Bylund, G.: Temperature-related absorption and excretion of oxytetracycline in rainbow trout (Salmo gairdneri R.). Aquaculture, 84:363-372, 1990. https://doi.org/10.1016/0044-8486(90)90101-R
  3. Coyne, R., Bergh, $\phi$., Samuelsen, O., Andersen, K., Lunestad, B.T., Nilsen, H., Dalsgaard, I. and Smith, P.: Attempt to validate breakpoint MIC values estimated from pharmacokinetic data obtained during oxolinic acid therapy of winter ulcer disease in Atlantic salmon (Salmo salar). Aquaculture, 238:51-66, 2004. https://doi.org/10.1016/j.aquaculture.2004.04.027
  4. Hustvedt, S.O. and Salte, R.: Distribution and elimination of oxolinic acid in rainbow trout (Oncorhynchus mykiss Walbaum) after a single rapid intravascular injection. Aquaculture, 92:297-303, 1991. https://doi.org/10.1016/0044-8486(91)90035-6
  5. Jarboe, H., Toth, B.R., Shoemaker, K.E., Greenlees, K.J. and Kleinow, K.M: Pharmacokinetics, bioavailability, plasma protein binding and disposition of nalidixic acid in rainbow trout (Oncorhynchus mykiss). Xenobiotica, 23:961-972, 1993. https://doi.org/10.3109/00498259309057035
  6. Katae, H., Kouno, K., Takase, Y., Miyazaki, H., Hashimoto, M. and Shimizu, M.: The evaluation of piromidic acid as an antibiotic in fish, an in vitro and in vivo study. J. Fish Dis., 2:321-335, 1979. https://doi.org/10.1111/j.1365-2761.1979.tb00174.x
  7. Poher, I., Blanc, G. and Loussouarn, S.: Pharmacokinetics of oxolinic acid in sea bass, Dicentrarchus Iabrax (L., 1758), after a single rapid intravascular injection. J. Vet. Pharmacol. Therap., 20:267-275, 1997. https://doi.org/10.1046/j.1365-2885.1997.00062.x
  8. Rigos, G., Alexis, M., Andriopoulou, A. and Nengas, I.: Temperature-dependent pharmacokinetics and tissue distribution of oxolinic acid in sea bass, Dicentrarchus labrax L., after a single intravascular injection. Aquacult. Res., 25:401-408, 2002a.
  9. Rigos, G., Alexis, M., Trypenou, A.E., Nengas, I., Piper, I. and Troisi, G.: Pharmacokinetics of oxolinic acid in gilthead sea bream, Sparus aurata L.. J. Fish. Dis., 25:401-408, 2002b. https://doi.org/10.1046/j.1365-2761.2002.00391.x
  10. Rigos, G., Tyrpenou, A.E., Nengas, I., Alexis, M., and Troisi, G.M.: The kinetic profile of oxolinic acid in sharpsnout sea bream, Diplodus puntazzo (Cetti 1777). Aquacult. Res., 35:1299-1304, 2004. https://doi.org/10.1111/j.1365-2109.2004.01127.x
  11. Rogstad, A., Ellingsen, O.F. and Syvertsen, C.:Pharmacokinetics and bioavailability of flumequine and oxolinic acid after various routes of administration to Atlantic salmon in seawater. Aquaculture, 110:207-220, 1993. https://doi.org/10.1016/0044-8486(93)90369-A
  12. Samuelson, O.B.: Pharmacokinetics of quinolones in fish: A review. Aquaculture, 255:55-75, 2006a.
  13. Samuelson, O.B.: Multiple dose pharmacokinetic study of oxolinic acid in cod, Gadus morhua L., Aquacult. Int., 14:443-450, 2006b. https://doi.org/10.1007/s10499-006-9047-0
  14. Samuelson, O.B., Bergh, $\phi$. and Ervik, A.: A singledose pharmacokinetic study of oxolinic acid ester, in cod, Gadus morhua L., held in sea water at 8${^{\circ}C}$ and in vitro antibacterial activity of oxolinic acid against Vibrio anguillarum strains isolated from diseased cod. J. Fish Dis., 26:339-347, 2003. https://doi.org/10.1046/j.1365-2761.2003.00466.x
  15. Samuelson, O.B. and Ervik, A.: A single-dose pharmacokinetic study of oxolinic acid and vetoquinol, an oxolinic acid ester, in Atlantic halibut, Hippoglossus hippoglossus L., held in sea water at 9${^{\circ}C}$. J. Fish Dis., 22:13-23, 1999. https://doi.org/10.1046/j.1365-2761.1999.00133.x
  16. Samuelson, O.B. and Ervik, A.: Absorption, tissue distribution and excretion of flumequine and oxolinic acid in corkwing wrasse (Symphodus melops) following a single intraperitoneal injection or bath treatment. J. Vet. Pharmacol. Therap., 24:111-116, 2001. https://doi.org/10.1046/j.1365-2885.2001.00319.x
  17. Samuelson, O.B., Ervik, A., Purse, L. and Smith, P.: Single-dose pharmacokinetic study of oxolinic acid and vetoquinol, an oxolinic acid ester, in atlantic salmon (Salmo salar) held in sea water and in vitro antibacterial activity of against Aeromonas salmonicida. Aquaculture, 187:213-224, 2000. https://doi.org/10.1016/S0044-8486(00)00315-X
  18. Sangrungruang, K., Endo, M. and Ueno, R.: Development of method for forced oral administration of xenobiotics in shrimp. Fish. Sci., 70:463-466, 2004. https://doi.org/10.1111/j.1444-2906.2004.00826.x
  19. Treves-Brown, K.M.: Tetracyclines. In Applied Fish Pharmacology. pp. 64-82. Kluwer Academic Publishers, Boston, London. 2000.
  20. Uno, K., Aoki, T., Ueno, R. and Maeda, I.:Pharmacokinetics of nalidixic acid and sodium nifurstyrenate in cultured fish following bolus intravascular administration. Fish Pathology, 31:191-196, 1996. https://doi.org/10.3147/jsfp.31.191
  21. Uno, K., Kato, M., Aoki, T., Kubota, S.S. and Ueno, R.: Pharmacokinetics of nalidixic acid in cultured rainbow trout and amago salmon. Aquaculture, 102:297-307, 1992. https://doi.org/10.1016/0044-8486(92)90183-L
  22. Zhang, Q. and Li, X.: Pharmacokinetics and residue elimination of oxytetracycline in grass carp, Ctenopharyngodon idellus. Aquaculture,272:140-145, 2007. https://doi.org/10.1016/j.aquaculture.2007.08.033
  23. 片江宏巳, 河野薰, 森川進, 田代文男, 高橋誓, 松丸豊, 牛山宗弘, 宮シ崎照雄, 窪田三朗: ピロミド酸に關する魚病化學療法的硏究-I. 魚類における吸收, 分布, 殘留性および安全性. 魚病硏究, 14:79-91, 1979.
  24. 老田哲也, 河野薰, 片江宏巳, 中村信一, 關根豊, 橋本E昌久: ウナギにおけるピロミド 酸および代謝物の組織內濃度. 日本水産 學會誌 599-1608, 1982.
  25. 국립수의과학검역원 고시 제007-25호 동물용의약품의 안전사용기준 2008.
  26. 국립수산과학원 병리연구과 수산용의약품 제품 요약 해설집 2009, 30-37, 52, 2009.
  27. 식품의약품안전청 고시 제006-15호 식품의 기준 및 규격 중 개정 2006.
  28. 식품의약품안전청 고시 제008-51호 식품의 기준 및 규격 중 개정 2008.
  29. 정승희, 김진우: 병용항균제의 어류질병 세균에 대한 시험관내 항균활성. 한국어병학회지 13: 45-51, 2000.
  30. 정승희, 최동림, 김진우, 조미라, 지보영, 서정수: Oxolinic acid의 경구투여, 주사 및 약욕에 따른 넙치, 체내 약물동태학적특성. 한국어병학회지 22:125-135, 2009.